Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

SHA:688273 Revenue

Nanjing Medlander Medical Technology had revenue of 99.20M CNY in the quarter ending March 31, 2026, a decrease of -16.13%. This brings the company's revenue in the last twelve months to 412.52M, down -5.92% year-over-year. In the year 2025, Nanjing Medlander Medical Technology had annual revenue of 431.59M with 1.66% growth.

• Revenue (ttm): 412.52M
• Revenue Growth: -5.92%
• P/S Ratio: 9.87
• Revenue / Employee: 750.03K
• Employees: 550
• Market Cap: 4.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	431.59M	7.04M	1.66%
Dec 31, 2024	424.55M	83.72M	24.57%
Dec 31, 2023	340.82M	-36.06M	-9.57%
Dec 31, 2022	376.89M	35.25M	10.32%
Dec 31, 2021	341.64M	5.12M	1.52%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error